IL127040A0 - Use of substituted azaspirane in the treatment of asthma - Google Patents

Use of substituted azaspirane in the treatment of asthma

Info

Publication number
IL127040A0
IL127040A0 IL12704097A IL12704097A IL127040A0 IL 127040 A0 IL127040 A0 IL 127040A0 IL 12704097 A IL12704097 A IL 12704097A IL 12704097 A IL12704097 A IL 12704097A IL 127040 A0 IL127040 A0 IL 127040A0
Authority
IL
Israel
Prior art keywords
asthma
treatment
azaspirane
substituted azaspirane
substituted
Prior art date
Application number
IL12704097A
Other languages
English (en)
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of IL127040A0 publication Critical patent/IL127040A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12704097A 1996-05-17 1997-05-15 Use of substituted azaspirane in the treatment of asthma IL127040A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1788996P 1996-05-17 1996-05-17
PCT/IB1997/000688 WO1997044030A1 (en) 1996-05-17 1997-05-15 Use of substituted azaspirane in the treatment of asthma

Publications (1)

Publication Number Publication Date
IL127040A0 true IL127040A0 (en) 1999-09-22

Family

ID=21785110

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12704097A IL127040A0 (en) 1996-05-17 1997-05-15 Use of substituted azaspirane in the treatment of asthma

Country Status (17)

Country Link
US (1) US6025364A (no)
EP (1) EP0910373A1 (no)
JP (1) JP2000513335A (no)
KR (1) KR20000010933A (no)
CN (1) CN1219129A (no)
AU (1) AU710542B2 (no)
BR (1) BR9709007A (no)
CA (1) CA2253217A1 (no)
CZ (1) CZ367598A3 (no)
HU (1) HUP0003908A3 (no)
IL (1) IL127040A0 (no)
NO (1) NO985325L (no)
NZ (1) NZ332627A (no)
PL (1) PL329931A1 (no)
SK (1) SK156698A3 (no)
WO (1) WO1997044030A1 (no)
ZA (1) ZA974271B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080408A2 (en) * 2003-03-10 2004-09-23 Callisto Pharmaceuticals, Inc. Method of treating cancer with azaspirane compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
CA2092177A1 (en) * 1990-09-24 1992-03-25 Alison Mary Badger Methods
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
US5482959A (en) * 1992-01-28 1996-01-09 Smithkline Beecham Corporation Method for delaying aids in an HIV infected individual by administration of substituted azaspirane compounds
GB9315340D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315306D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods
GB9315351D0 (en) * 1993-07-23 1993-09-08 Smithkline Beecham Corp Methods

Also Published As

Publication number Publication date
CN1219129A (zh) 1999-06-09
AU2973997A (en) 1997-12-09
HUP0003908A3 (en) 2001-04-28
NO985325D0 (no) 1998-11-16
NO985325L (no) 1998-11-16
PL329931A1 (en) 1999-04-26
EP0910373A1 (en) 1999-04-28
JP2000513335A (ja) 2000-10-10
WO1997044030A1 (en) 1997-11-27
KR20000010933A (ko) 2000-02-25
CA2253217A1 (en) 1997-11-27
US6025364A (en) 2000-02-15
ZA974271B (en) 1998-08-25
AU710542B2 (en) 1999-09-23
BR9709007A (pt) 2000-01-04
CZ367598A3 (cs) 1999-05-12
HUP0003908A2 (en) 2001-03-28
NZ332627A (en) 2001-06-29
SK156698A3 (en) 1999-06-11

Similar Documents

Publication Publication Date Title
GB2331015B (en) Therapeutic methods and compositions involving isoflavones
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
HRP970680B1 (en) New ketobenzamides and their use
IL116325A0 (en) Substituted 1h-imidazoles their preparation and use
SG55368A1 (en) Abrasive composition and use of the same
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
GB9418420D0 (en) Composition for the treatment of an energy imbalance in ruminents
EP0756636A4 (en) CHONDROITINASES I AND II, PROCESSES FOR THEIR PREPARATION AND THEIR USE
ZA979731B (en) Treatment of asthma.
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
ZA954984B (en) Compositions and methods for the treatment of tumors
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
ZA973843B (en) Treatment of asthma with TNFR-lg.
GB9620777D0 (en) Therapeutic use
HUP9902802A3 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
IL127040A0 (en) Use of substituted azaspirane in the treatment of asthma
EP0872219A4 (en) APPLICATION OF THE BIOFREQUENCY SPECT IN EMBYOTHECHNOLOGY IN ANIMALS
GB9609944D0 (en) An improvement in the treatment of wastes
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB9603471D0 (en) Therapeutic methods and compositions for use therein
SI1011649T1 (en) Use of endipalene in the treatment of psoriasis
IL148863A0 (en) Components for use in producing paclitaxal and methods for the preparation thereof
ZA951726B (en) Carbamoylcarboxamides their preparation and their use
GB9621314D0 (en) Substances and their therapeutic use